Prevalence, severity stages, and risk factors of diabetic retinopathy in 1464 adult patients with type 1 diabetes

被引:8
作者
Zureik, Abir [1 ]
Julla, Jean-Baptiste [2 ,3 ,4 ]
Erginay, Ali [1 ]
Vidal-Trecan, Tiphaine [2 ,3 ,4 ]
Juddoo, Vanessa [2 ,3 ,4 ]
Gautier, Jean-Francois [2 ,3 ,4 ]
Massin, Pascale [1 ]
Tadayoni, Ramin [1 ]
Riveline, Jean-Pierre [2 ,3 ,4 ]
Couturier, Aude [1 ]
机构
[1] Univ Paris, Lariboisiere Hosp, AP HP, Ophthalmol Dept, F-75010 Paris, France
[2] Univ Paris, Lariboisiere Hosp, AP HP, Dept Diabetol & Endocrinol, Paris, France
[3] Ctr Rech Cordeliers, Unite INSERM U1138 Immun & Metab Diabet, ImMeDiab Team, Paris, France
[4] Univ Paris, Paris, France
关键词
Diabetic retinopathy; Prevalence; Risk factors; Type; 1; diabetes; Epidemiology; GENDER-DIFFERENCES; MACULAR EDEMA; PROGRESSION; MELLITUS; REGISTRY; DISEASE; PEOPLE; EYE;
D O I
10.1007/s00417-021-05298-7
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To determine the prevalence of diabetic retinopathy (DR) and its risk factors in adult type 1 diabetes (T1D) patients Methods: In this cross-sectional study, all T1D patients followed in the University Center for Diabetes and its Complications of Lariboisiere Hospital (Paris, France) between January 2017 and February 2019 were included. Ophthalmologic and systemic data were collected from electronic records. The association between DR (and each grade) and associated factors were estimated by univariate and multivariate analyses using logistic regression models. Results: A total of 1464 patients (46.2% of women, mean age: 42.2 +/- 15.8 years) were included. The mean hemoglobin A1c (HbA1c) was 7.8 +/- 1.7% and the mean diabetes duration was 20.5 +/- 13.5 years. DR prevalence was 50.1% (47.4-52.6) and the prevalence of mild, moderate, and severe non-proliferative DR and proliferative DR was 19.1%, 9.4%, 3.9%, and 17.6%, respectively. DR was significantly associated with male gender, an older age, former and current smoking status, a higher BMI, the presence of nephropathy and neuropathy, higher HBA1c, and longer diabetes duration. Patients with HbA1c > 10% had an adjusted odds ratio (OR) of 3.25 (1.77-6.01) of having DR compared to patients with HbA1c < 6.5%. Patients with a diabetes duration > 30 years had an adjusted OR of 24.87 (14.82-42.67) higher of having DR compared to patients with a diabetes duration < 10 years. Conclusion: In this study, 50.1% of adult T1D patients had DR and 17.6% had proliferative DR. Diabetes duration and HbA1c were major risk factors.
引用
收藏
页码:3613 / 3623
页数:11
相关论文
共 38 条
  • [1] Mechanisms of Disease Diabetic Retinopathy
    Antonetti, David A.
    Klein, Ronald
    Gardner, Thomas W.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (13) : 1227 - 1239
  • [2] The association of smoking and risk of diabetic retinopathy in patients with type 1 and type 2 diabetes: a meta-analysis
    Cai, Xiaoling
    Chen, Yifei
    Yang, Wenjia
    Gao, Xueying
    Han, Xueyao
    Ji, Linong
    [J]. ENDOCRINE, 2018, 62 (02) : 299 - 306
  • [3] Ten-year incidence and assessment of safe screening intervals for diabetic retinopathy: the OPHDIAT study
    Chamard, Chloe
    Daien, Vincent
    Erginay, Ali
    Gautier, Jean-Francois
    Villain, Max
    Tadayoni, Ramin
    Carriere, Isabelle
    Massin, Pascale
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2021, 105 (03) : 432 - 439
  • [4] Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes - The EURODIAB Prospective Complications Study
    Chaturvedi, N
    Sjoelie, AK
    Porta, M
    Aldington, SJ
    Fuller, JH
    Songini, M
    Kohner, EM
    [J]. DIABETES CARE, 2001, 24 (02) : 284 - 289
  • [5] Global prevalence of diabetic retinopathy: protocol for a systematic review and meta-analysis
    Cheloni, Riccardo
    Gandolfi, Stefano A.
    Signorelli, Carlo
    Odone, Anna
    [J]. BMJ OPEN, 2019, 9 (03):
  • [6] Diabetic retinopathy
    Cheung, Ning
    Mitchell, Paul
    Wong, Tien Yin
    [J]. LANCET, 2010, 376 (9735) : 124 - 136
  • [7] Epidemiology of diabetic retinopathy: Expected vs reported prevalence of cases in the French population
    Delcourt, C.
    Massin, P.
    Rosilio, A.
    [J]. DIABETES & METABOLISM, 2009, 35 (06) : 431 - 438
  • [8] Delcourt C, 2018, MED MALADIES METABOL, V12, P553, DOI [10.1016/S1957-2557(18)30149-4, DOI 10.1016/S1957-2557(18)30149-4]
  • [9] Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study
    Hainsworth, Dean P.
    Bebu, Ionut
    Aiello, Lloyd P.
    Sivitz, William
    Gubitosi-Klug, Rose
    Malone, John
    White, Neil H.
    Danis, Ronald
    Wallia, Amisha
    Gao, Xiaoyu
    Barkmeier, Andrew J.
    Das, Arup
    Patel, Shriji
    Gardner, Thomas W.
    Lachin, John M.
    [J]. DIABETES CARE, 2019, 42 (05) : 875 - 882
  • [10] Diabetic retinopathy in type 1 diabetes patients in Western Norway
    Jansson, Ragnhild W.
    Hufthammer, Karl Ove
    Krohn, Jorgen
    [J]. ACTA OPHTHALMOLOGICA, 2018, 96 (05) : 465 - 474